close

Interleukin Genetics, Inc., together with its subsidiaries, focuses on developing, acquiring, and commercializing personalized health products that help individuals improve and maintain their health through preventive measures in the United States and internationally. It conducts, researches, develops, markets, and sells genetic test panels primarily in inflammatory and metabolic areas to provide insight into health, wellness, and disease. The company markets and distributes genetic tests under the GENSONA brand, through a strategic partnership with Alticor; and PST tests through sales and marketing partners to dentists and periodontists. It offers genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. The company has research collaborations with the University of Sheffield, Tufts University, New York University, Harvard University, the Mayo Clinic, California Pacific Medical Center, Boston University, the University of Arkansas, Tongji Medical College, University of North Carolina, and Yonsei University. Interleukin Genetics, Inc. was founded in 1986 and is headquartered in Waltham, Massachusetts.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	0.00
Volume	0
Volume Avg	58871
52 Week High	3.00
52 Week Low	0.28
PE	N/A
PE (group average)	39
EPS Year	0.00
EPS change Q/Q	0%
EPS change Q/Q Yr ago	-25%
EPS change Q/Q next Q est	100%
EPS change Y/Y	-28.13%
REV change Q/Q	100%
REV change Q/Q Yr ago	33.33%
EPS next Q est	0.00
EPS next Y est	0.00
Divident Annual	0.00
Dividend Yield	0%